Key takeaways
- Most testosterone therapy side effects are early, self-limiting adjustments — water retention, acne and mild mood changes that settle as levels stabilise over the first four to six weeks.
- Rising hematocrit is the effect most likely to force a change in protocol, and it is entirely manageable when someone is measuring it.
- Timing is most of the answer, since the same symptom means different things at different points.
- Testosterone raises red cell production through more than one route.
Most of what gets called a TRT side effect is one of three things: a predictable early adjustment that resolves on its own, a lab value drifting and being caught, or a consequence of the dose being wrong. Very little of it is mysterious, and almost all of it is visible on a blood panel before it is visible in the mirror. What follows is the honest list — what happens, why, when, and what is done about it.
What happens when
Timing is most of the answer, since the same symptom means different things at different points.
Weeks 1-4. Levels are still climbing toward a steady state: water retention, mild puffiness, a bump in libido, oilier skin, mood that can feel amplified either way. None of it is the final state of anything, which is why judging a protocol in the first month is a mistake.
Weeks 6-12. Levels have stabilised and the first meaningful panel is drawn. Hematocrit and estradiol have had time to move. This is where a protocol gets adjusted, and where most problems get caught before they become real.
Beyond three months. What remains is either part of your response to testosterone or a signal the dose is too high, and monitoring exists to separate the two. The first 30 days covers the early window.
The common ones, and why they happen
- Water retention, weeks 1-4. Testosterone and the estradiol made from it both influence sodium and fluid handling. It settles as levels stabilise.
- Acne and oily skin. Sebaceous glands carry androgen receptors, and testosterone converted locally to DHT drives sebum production. Most common in men whose skin was androgen-reactive in adolescence; usually improves after a few months.
- Mild hematocrit elevation — typically from around 44% into the 48-50% range. Expected, monitored, discussed below.
- Suppressed fertility. Universal on testosterone alone. Not a side effect so much as an unavoidable consequence of the mechanism, covered in fertility on TRT.
- Hair changes. More body and facial hair; where androgenetic alopecia is already genetically in play, scalp thinning can accelerate. This tracks DHT sensitivity at the follicle rather than the testosterone number — see does TRT cause hair loss.
- Mild emotional changes in the first month while levels move. Usually a lift rather than a problem.
Hematocrit is the one that actually needs watching
Testosterone raises red cell production through more than one route. It stimulates erythropoietin, increases the marrow's sensitivity to it, and suppresses hepcidin — the hormone restricting how much iron reaches the circulation. Less hepcidin means more iron available for haemoglobin synthesis (Bachman et al., J Gerontol A Biol Sci Med Sci 2014). The result is a reliable, dose-related rise in red cell mass, and it is the most common reason a protocol gets changed (Ohlander et al., Sex Med Rev 2018).
The thresholds in practice: a drift into the high 40s is expected and generally left alone. Above roughly 52% it is addressed — usually by lowering the dose or shortening the injection interval so peaks are smaller, sometimes by blood donation. Above 54%, or haemoglobin above 18, the protocol changes. Two things routinely inflate the reading and are excluded first: dehydration and untreated sleep apnoea. Hematocrit management on TRT has the decision tree.
Estradiol: the side effect people create by treating it
Some testosterone aromatises into estradiol. That is normal physiology, and men need estradiol — it is the dominant regulator of bone turnover in men as well as women (testosterone and bone density covers why). If it rises far enough it produces water retention, nipple tenderness, mood changes and, at the extreme, breast tissue growth.
The common error is reaching for an aromatase inhibitor first. Crushing estradiol produces its own picture — joint pain, flat mood, low libido, poor sleep — and removes bone protection while the testosterone number still looks excellent on paper. The better first step is the dose or the injection frequency, since aromatisation rises with the peak. Test with a sensitive assay, treat symptoms rather than the number, and add a blocker only when confirmed. Estradiol on TRT covers the sequence.
Fertility, and why it is not optional
Exogenous testosterone suppresses the pituitary signal telling the testes to work. Without LH and FSH, intratesticular testosterone falls to a fraction of what sperm production requires and output drops; testicular volume often falls with it. This is predictable rather than a sign something went wrong, and it is the most important thing to raise before starting if children are a possibility. Sperm banking, or a protocol that maintains testicular signalling, are both far easier to arrange in advance than to retrofit.
Recovery after stopping is usual but not guaranteed, and is measured in months rather than weeks, with a wide spread between individuals (Liu et al., Lancet 2006).
Less common, monitorable
- Significant erythrocytosis — hematocrit above 54% or haemoglobin above 18. Managed with dose reduction, smaller more frequent doses, hydration and, if needed, phlebotomy.
- Worsened obstructive sleep apnoea in men who already have it (Killick et al., J Sleep Res 2013). Worth screening for first, given the overlap between low testosterone, poor sleep and excess weight.
- Gynecomastia, where estradiol has run high unaddressed for a long period. Early tenderness is reversible; established glandular tissue is much less so.
- Irritability or aggression. Usually a peak-trough problem rather than a testosterone problem, and usually resolved by flattening the curve.
Rare
- Meaningful lipid changes. Most men see lipids unchanged or improved; a minority see HDL drop modestly.
- Severe mood disturbance. Investigate the reversible causes first — crashed estradiol, high hematocrit, untreated apnoea, thyroid — before blaming testosterone.
- Injection site reactions. Almost always technique: needle length, injection speed, site rotation.
The concerns that have been resolved
- Cardiovascular events. TRAVERSE randomised 5,200 men with existing cardiovascular disease or high risk over 33 months and found no increase in major adverse cardiac events versus placebo (Lincoff et al., N Engl J Med 2023). It did report more atrial fibrillation, pulmonary embolism and acute kidney injury, which is worth knowing rather than glossing over.
- Prostate cancer. Meta-analysis has not supported a causal link with physiologic testosterone therapy (Cui et al., Prostate Cancer Prostatic Dis 2014). PSA is still monitored — see PSA on TRT.
- Heart attack risk. The observational signal that started the alarm has not replicated in randomised trials (Vigen et al., JAMA 2013).
Guidance still frames treatment as appropriate for men with symptoms and unequivocally low levels on repeat morning testing, not a number alone (Bhasin et al., J Clin Endocrinol Metab 2018).
How each is actually handled
| Side effect | First move |
|---|---|
| Water retention | Wait four weeks; reduce sodium temporarily |
| Acne | Skincare; usually settles as levels stabilise |
| Raised hematocrit | Hydration, smaller more frequent doses, then donation |
| Fertility loss | Decide before starting: bank sperm, or preserve testicular signalling |
| Estradiol symptoms | Sensitive assay, then dose or frequency; blocker only if confirmed |
| Sleep apnoea | Screen at baseline; treat it before blaming the testosterone |
| Gynecomastia | Act on early tenderness rather than waiting |
The principle: nearly every bad TRT story traces to one of two things — no monitoring, or an unsupervised product from a source that never intended to monitor anything. None of the effects listed here are exotic. They are visible on an ordinary blood panel months before they cause trouble.
Bottom line
Testosterone therapy has real side effects, and the honest list is neither the promotional one nor the alarmed one. Water retention, acne and mood changes are early and self-limiting. Rising hematocrit is the effect most likely to force a change, and is manageable when measured. Fertility suppression is a certainty to plan around rather than a risk to accept. Estradiol problems are frequently created by over-treating estradiol. The historical fears have not held up under randomised evidence, though the trial that cleared the cardiovascular question found other signals worth respecting. What separates a good outcome from a bad one is whether anyone is reading the labs.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
